Cite
MLA Citation
Christine Katlama et al.. “Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response.” Journal of antimicrobial chemotherapy, vol. 75, 2020, pp. 3699–3700. http://access.bl.uk/ark:/81055/vdc_100117113991.0x000030